A panel of experts recommended on Wednesday the removal of the “clinical trial mode” label attached to the emergency authorization of Bharat Biotech’s Covid-19 Covaxin vaccine, The Indian Express has learned. The recommendation of the Subject Matter Expert Committee (SEC), if accepted by the head of India’s main drug regulatory …
Read More »Covaxin booster: SEC says to remove label from clinical trial mode
